UMIN-CTR Clinical Trial

Recruitment status Suspended
Unique ID issued by UMIN UMIN000045346
Receipt No. R000047554
Scientific Title Study on cancer patient parameters.
Date of disclosure of the study information 2021/09/02
Last modified on 2021/09/02 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title KUMAMON cancer registry
Acronym KUMAMON cancer registry
Scientific Title Study on cancer patient parameters.
Scientific Title:Acronym Study on cancer patient parameters.
Region
Japan

Condition
Condition malignant disease
Classification by specialty
Hematology and clinical oncology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The progress in cancer treatment has been remarkable, and in addition to surgical treatment, chemotherapy with various targeted drugs and new radiation therapy have been developed, and the survival rate of cancer patients has been greatly improved. Along with this, there are some reports that the onset of cardiovascular disease affects the prognosis of cancer patients.
Basic objectives2 Others
Basic objectives -Others Currently, studies are underway to identify new biomarkers for the pathogenesis of cardiovascular disease such as arteriosclerosis and coronary artery disease in cancer patients. This time, in this study, diagnosis of various cardiovascular diseases (ischemic heart disease/peripheral artery disease, cardiomyopathy, heart failure, arrhythmia, valvular heart disease, aortic aneurysm, aortic dissection, venous thrombosis), determination of severity and therapeutic effect, We will search for biomarkers that can be prognostic and examine their usefulness.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes all cause mortality
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
1 years-old <=
Age-upper limit
120 years-old >
Gender Male and Female
Key inclusion criteria Cancer patients who are registered in the Cancer Registration Section of our hospital.
Key exclusion criteria none
Target sample size 35000

Research contact person
Name of lead principal investigator
1st name Daisuke
Middle name
Last name Sueta
Organization Kumamoto University
Division name Cardiovascular Medicine
Zip code 860-8556
Address 1-1-1, Honjo, Kumamoto
TEL 096-373-5175
Email sueta-d@kumamoto-u.ac.jp

Public contact
Name of contact person
1st name Daisuke
Middle name
Last name Sueta
Organization Kumamoto University
Division name Cardiovascular Medicine
Zip code 860-8556
Address 1-1-1, Honjo, Kumamoto
TEL 096-373-5175
Homepage URL
Email sueta-d@kumamoto-u.ac.jp

Sponsor
Institute Kumamoto University
Institute
Department

Funding Source
Organization self-funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kumamoto University
Address 1-1-1, Honjo, Kumamoto
Tel 096-373-5175
Email sueta-d@kumamoto-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 09 Month 02 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Suspended
Date of protocol fixation
2021 Year 09 Month 01 Day
Date of IRB
2020 Year 02 Month 20 Day
Anticipated trial start date
2021 Year 10 Month 01 Day
Last follow-up date
2025 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information observation study

Management information
Registered date
2021 Year 09 Month 02 Day
Last modified on
2021 Year 09 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047554